You act as a paraphrase tool. Your role involves understanding the provided text…
- User
System: You act as a paraphrase tool. Your role involves understanding the provided text and then providing a positive example that keeps the original meaning of the text unchanged while using synonyms, interchanging, adding or removing words or sentences, and then provide a negative example where the meaning of the original text is at its opposite. Output your response with the following format : Positive : Negative :
User: Once a product is approved, numerous post-approval requirements apply. Among other things, the holder of an approved NDA is subject to periodic and other FDA monitoring and reporting obligations, including obligations to monitor and report adverse events and instances of the failure of a product to meet the specifications in the NDA. Application holders must submit new or supplemental applications and obtain FDA approval for certain changes to the approved product, product labeling, or manufacturing process. Application holders must also submit advertising and other promotional material to the FDA and report on ongoing clinical studies. Depending on the circumstances, failure to meet these post-approval requirements can result in criminal prosecution, fines, injunctions, recall or seizure of products, total or partial suspension of production, denial or withdrawal of pre-marketing product approvals, or refusal to allow us to enter into supply contracts, including government contracts. In addition, even if we comply with FDA and other requirements, new information regarding the safety or effectiveness of a product could lead the FDA to modify or withdraw product approval. Assistant:
- Assistant
Positive: Once a product gains approval, various post-approval duties arise. For instance, the individual with an approved NDA must comply with regular and other FDA inspections and reporting responsibilities, which include tracking and reporting negative reactions and any failures of a product to meet NDA specifications. NDA holders are required to submit new or supplement applications and seek FDA authorization for specific modifications to the approved product, its labeling, or the production process. They also need to present advertising and promotional materials to the FDA and provide updates on ongoing clinical trials. Depending on the situation, not adhering to these post-approval duties may lead to criminal charges, monetary penalties, prohibitions, product recalls or seizures, full or partial halts in production, refusal or withdrawal of pre-marketing product approvals, or denial to engage in supply contracts, including those with the government. Moreover, even when FDA and other obligations are met, new findings about a product's safety or effectiveness might cause the FDA to alter or revoke the product approval.
Negative: Once a product is approved, there are no further requirements to follow. The holder of an approved NDA does not need to bother with monitoring or reporting to the FDA, nor are they required to manage adverse event reports or check if a product meets NDA specifications. They aren't obligated to file any additional applications or seek FDA approval for any product changes. Submitting advertising or promotional materials to the FDA, or reporting on clinical studies is unnecessary. Regardless of the situation, failing to follow post-approval requirements results in no significant consequences or punishments. Additionally, even if FDA requirements are eventually disregarded, new safety or effectiveness information will not affect the FDA's product approval.